MedPath

Impact of markers like D-Dimer and Coagulation parameters in predicting outcome in COVID-19 patients

Not yet recruiting
Conditions
Coronavirus as the cause of diseases classified elsewhere,
Registration Number
CTRI/2021/04/033047
Lead Sponsor
Kowshik V
Brief Summary

The study is prospective and will take place in the Department of General Medicine, Sri Ramachandra Institute of Higher Education and Research, Porur ,Chennai between March 2021 and March 2023 after obtaining ethical clearance. It aims to evaluate the prognostic role of D-Dimer with illness severity. We also aim to observe the coagulation parameters (PT, PTT and INR) in patients with elevated D-Dimer and assess its correlation with complications and outcome. The identification of effective laboratory biomarkers capable of triaging patients with COVID-19 infection is very necessary taking into account the unpredictable course of the disease. Studies have shown a significant relation between D-Dimer levels and disease progression. Using the pre-structured proforma, patient’s clinical and laboratory data are collected and analysed after getting their consent. D-dimer values, course in hospital - oxygen requirement , drugs used with dosage, complications or adverse events that have occurred will all be recorded and statistical analysis will be done to correlate the two. The results of our study will help prompt triaging of the high risk patients and help rethink our treatment approach.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
400
Inclusion Criteria

RT-PCR of nasopharyngeal or oropharyngeal swab confirmed COVID-19 patients more than or equal to 18 years of age and either gender hospitalized for the illness.

Exclusion Criteria

COVID-19 positive patients less than 18 years of age Patients on pre-hospitalization anti-coagulation Patients with cancer and prior thrombocytopenia or coagulopathy Patients having hospital stay less than 3 days.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical recovery of the patientAt baseline at 4 weeks
Secondary Outcome Measures
NameTimeMethod
Complications during the hospital stay and immediately after dischargeAt baseline at 4 weeks

Trial Locations

Locations (1)

Sri Ramachandra Institute of Higher Education and Research

🇮🇳

Chennai, TAMIL NADU, India

Sri Ramachandra Institute of Higher Education and Research
🇮🇳Chennai, TAMIL NADU, India
Kowshik V
Principal investigator
8220281380
vkowshik94@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.